CANSINOBIO News

CANSINOBIO: 2023 Environmental, Social and Governance & Corporate Social Responsibility Report

Apr 24 09:07 ET

CANSINOBIO: VOLUNTARY ANNOUNCEMENT - HAEMOPHILUS INFLUENZAE TYPE B CONJUGATE VACCINE, FREEZE-DRIED OBTAINS CLINICAL TRIAL APPROVAL

Apr 22 06:55 ET

CANSINOBIO: VOLUNTARY ANNOUNCEMENT - POSITIVE PRELIMINARY PHASE I CLINICAL RESULTS FOR PROTEIN-BASED PNEUMOCOCCAL VACCINE

Apr 21 06:19 ET

CANSINOBIO: An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section

Apr 11 07:34 ET

CANSINOBIO: An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section

Apr 11 07:29 ET

CANSINOBIO: An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section

Apr 11 07:24 ET

CANSINOBIO: An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section

Apr 3 05:35 ET

CANSINOBIO: Monthly Return of Equity Issuer on Movements in Securities

Apr 2 23:15 ET

CANSINOBIO: An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section

Mar 27 10:49 ET

CANSINOBIO: VOLUNTARY ANNOUNCEMENT - INITIATION OF PHASE III CLINICAL TRIAL AND COMPLETION OF FIRST PATIENT ENROLLMENT FOR ABSORBED TETANUS VACCINE

Mar 20 05:25 ET

CANSINOBIO: An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section

Mar 13 10:43 ET

CANSINOBIO: Monthly Return of Equity Issuer on Movements in Securities

Mar 1 04:29 ET

CANSINOBIO: VOLUNTARY ANNOUNCEMENT - ACCEPTANCE OF DRUG REGISTRATION APPLICATION FOR 13-VALENT PNEUMOCOCCAL CONJUGATE VACCINE (CRM197, TT VECTOR)

Feb 28 04:32 ET

CANSINOBIO: List of Directors and their Roles and Functions

Feb 23 07:35 ET

CANSINOBIO: ELECTIONS RELATING TO BOARD OF DIRECTORS, BOARD COMMITTEES AND BOARD OF SUPERVISORS

Feb 23 07:31 ET

CANSINOBIO: ARTICLES OF ASSOCIATION

Feb 21 08:55 ET

CANSINOBIO: List of Directors and their Roles and Functions

Feb 21 08:49 ET

CANSINOBIO: FURTHER ELABORATION OF CUMULATIVE VOTING SYSTEM TO BE ADOPTED FOR CERTAIN RESOLUTIONS PROPOSED AT THE 2024 FIRST EGM

Feb 5 07:11 ET

CANSINOBIO: INSIDE INFORMATION DECONSOLIDATION OF CANSINO SPH BIOLOGICS INC.

Feb 2 04:50 ET

CANSINOBIO: Monthly Return of Equity Issuer on Movements in Securities

Feb 2 01:58 ET